Integral Derivatives’s Express Scripts Holding Company ESRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-13,101
Closed -$993K 1221
2016
Q2
$993K Buy
13,101
+6,664
+104% +$490K 0.02% 421
2016
Q1
$442K Buy
6,437
+3,160
+96% +$227K 0.01% 551
2015
Q4
$286K Sell
3,277
-6,400
-66% -$548K 0.01% 829
2015
Q3
$783K Buy
9,677
+7,328
+312% +$638K 0.02% 574
2015
Q2
$209K Buy
+2,349
New +$205K 0.01% 973
2015
Q1
Sell
-13,513
Closed -$1.13M 1512
2014
Q4
$1.14M Buy
13,513
+1,600
+13% +$125K 0.02% 623
2014
Q3
$841K Buy
11,913
+2,150
+22% +$153K 0.02% 787
2014
Q2
$677K Buy
+9,763
New +$687K 0.01% 834

Other funds holding ESRX

Integral Derivatives's ESRX Position: Q3 2016 in Review

Integral Derivatives sold out of Express Scripts Holding Company (ESRX) in Q3 2016, closing a stake of 13,101 shares — an estimated $993K sold.

Integral Derivatives first reported a position in ESRX in Q2 2014 and held it in 8 quarters. The position peaked at $1.14M in Q4 2014. 1,150 funds tracked by Wall St. Rank hold ESRX as of Q3 2016.

  • Integral Derivatives reported no remaining Express Scripts Holding Company position as of Q3 2016 after selling out during the quarter.
  • Integral Derivatives sold 13,101 Express Scripts Holding Company shares in Q3 2016, an estimated $993K.
  • Integral Derivatives first reported a position in Express Scripts Holding Company in Q2 2014 and held it in 8 quarters.
  • Integral Derivatives's Express Scripts Holding Company position peaked at $1.14M in Q4 2014.
  • 1,150 funds tracked by Wall St. Rank held Express Scripts Holding Company as of Q3 2016.

Based on Integral Derivatives's 13F filing for Q3 2016, filed 14 Nov 2016.